Wen-Qiang Wei1, Chang-Qing Hao2, Chen-Tao Guan3, Guo-Hui Song4, Meng Wang3, De-Li Zhao5, Bian-Yun Li6, Wen-Long Bai7, Pei-Yong Hou8, Jin-Wu Wang9, Guo-Liang Jin10, Fu-Hua Lei11, Xin-Qing Li3, Li-Yan Xue12, Guo-Qing Wang3, Christian C Abnet13, Philip R Taylor13, Sanford M Dawsey13, You-Lin Qiao3. 1. National Central Cancer Registry, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. 2. Department of Endoscopy, Cancer Institute/Hospital of Linzhou, Linzhou, China. 3. Department of Cancer Epidemiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. 4. Department of Epidemiology, Cancer Institute/Hospital of Ci County, Ci County, China. 5. Center of Cancer Prevention and Treatment, People's Hospital of Feicheng, Feicheng, China. 6. Department of Epidemiology, Cancer Institute/Hospital of Linzhou, Linzhou, China. 7. Department of Endoscopy, Cancer Institute/Hospital of Ci County, Ci County, China. 8. Department of Endoscopy, People's Hospital of Feicheng, Feicheng, China. 9. Department of Pathology, Cancer Institute/Hospital of Linzhou, Linzhou, China. 10. Department of Pathology, Cancer Institute/Hospital of Ci County, Ci County, China. 11. Department of Pathology, People's Hospital of Feicheng, Feicheng, China. 12. Department of Pathology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. 13. Metabolic Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Bethesda, Maryland, USA.
Abstract
INTRODUCTION: Data on the associations between esophageal histological lesions and risk of esophageal squamous cell carcinoma (ESCC) in general populations are limited. We aimed to investigate these associations in a large Chinese general population to inform future Chinese ESCC screening guidelines. METHODS: We performed endoscopic screening of 21,111 participants aged 40-69 years from 3 high-risk areas of China in 2005-2009, and followed the cohort through 2016. Cumulative incidence and mortality rates of ESCC were calculated by baseline histological diagnosis, and hazard ratios of ESCC, overall and by age and sex, were assessed using the Cox proportional hazards models. RESULTS: We identified 143 new ESCC cases (0.68%) and 62 ESCC deaths (0.29%) during a median follow-up of 8.5 years. Increasing grades of squamous dysplasia were associated with the increasing risk of ESCC incidence and mortality. The cumulative ESCC incidence rates for severe dysplasia/carcinoma in situ, moderate dysplasia (MD), and mild dysplasia were 15.5%, 4.5%, and 1.4%, respectively. Older individuals (50-69 years) had 3.1 times higher ESCC incidence than younger individuals (40-49 years), and men had 2.4 times higher ESCC incidence than women. DISCUSSION: This study confirmed that increasing grades of squamous dysplasia are associated with increasing risk of ESCC and that severe dysplasia and carcinoma in situ require clinical treatment. This study suggests that in high-risk areas of China, patients with endoscopically worrisome MD should also receive therapy, the first screening can be postponed to 50 years, and endoscopic surveillance intervals for unremarkable MD and mild dysplasia can be lengthened to 3 and 5 years, respectively.
INTRODUCTION: Data on the associations between esophageal histological lesions and risk of esophageal squamous cell carcinoma (ESCC) in general populations are limited. We aimed to investigate these associations in a large Chinese general population to inform future Chinese ESCC screening guidelines. METHODS: We performed endoscopic screening of 21,111 participants aged 40-69 years from 3 high-risk areas of China in 2005-2009, and followed the cohort through 2016. Cumulative incidence and mortality rates of ESCC were calculated by baseline histological diagnosis, and hazard ratios of ESCC, overall and by age and sex, were assessed using the Cox proportional hazards models. RESULTS: We identified 143 new ESCC cases (0.68%) and 62 ESCC deaths (0.29%) during a median follow-up of 8.5 years. Increasing grades of squamous dysplasia were associated with the increasing risk of ESCC incidence and mortality. The cumulative ESCC incidence rates for severe dysplasia/carcinoma in situ, moderate dysplasia (MD), and mild dysplasia were 15.5%, 4.5%, and 1.4%, respectively. Older individuals (50-69 years) had 3.1 times higher ESCC incidence than younger individuals (40-49 years), and men had 2.4 times higher ESCC incidence than women. DISCUSSION: This study confirmed that increasing grades of squamous dysplasia are associated with increasing risk of ESCC and that severe dysplasia and carcinoma in situ require clinical treatment. This study suggests that in high-risk areas of China, patients with endoscopically worrisome MD should also receive therapy, the first screening can be postponed to 50 years, and endoscopic surveillance intervals for unremarkable MD and mild dysplasia can be lengthened to 3 and 5 years, respectively.
Authors: Michael M Mwachiro; Stephen L Burgert; Justus Lando; Robert Chepkwony; Collins Bett; Claire Bosire; Christian C Abnet; Jessie Githanga; Wairimu Waweru; Carol A Giffen; Gwen Murphy; Russell E White; Mark D Topazian; Sanford M Dawsey Journal: Am J Gastroenterol Date: 2016-02-23 Impact factor: 10.864
Authors: S M Dawsey; K J Lewin; G Q Wang; F S Liu; R K Nieberg; Y Yu; J Y Li; W J Blot; B Li; P R Taylor Journal: Cancer Date: 1994-09-15 Impact factor: 6.860
Authors: S M Dawsey; D E Fleischer; G Q Wang; B Zhou; J A Kidwell; N Lu; K J Lewin; M J Roth; T L Tio; P R Taylor Journal: Cancer Date: 1998-07-15 Impact factor: 6.860
Authors: Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal Journal: CA Cancer J Clin Date: 2018-09-12 Impact factor: 508.702
Authors: Yi Qin; William Taylor; William R Bamlet; Adharsh Ravindran; Alessia Buglioni; Xiaoming Cao; Patrick H Foote; Seth W Slettedahl; Douglas W Mahoney; Paul S Albert; Sungduk Kim; Nan Hu; Philip R Taylor; Arash Etemadi; Masoud Sotoudeh; Reza Malekzadeh; Christian C Abnet; Thomas C Smyrk; David Katzka; Mark D Topazian; Sanford M Dawsey; David Ahlquist; John B Kisiel; Prasad G Iyer Journal: Cancer Epidemiol Biomarkers Prev Date: 2020-09-18 Impact factor: 4.254